- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

FDA Approves Lucentis for Treatment of Retinal Vein Occlusion

Posted By Dr. Ari Weitzner On June 25, 2010 @ 8:05 pm In Retina | 4 Comments

After a six-month review, the FDA has updated the indication for the injectable macular degeneration drug ranibizumab (Lucentis) for the treatment of retinal vein occlusion. The approval was based on the results of two studies that pooled data from 789 patients with macular edema after central and branch retinal vein occlusion, comparing results using 0.3 mg and 0.5 mg ranibizumab injections against placebo with best-corrected visual acuity ratings after six months.

Read the full story here [1] on MedPage Today.


Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/003230-fda-approves-lucentis-for-treatment-of-retinal-vein-occlusion/

URLs in this post:

[1] here: http://www.medpagetoday.com/Ophthalmology/GeneralOphthalmology/20851

Copyright © 2008 Eye Doc Talk. All rights reserved.